Accelerating Diagnostics in a Time of Crisis (eBook, ePUB)
The Response to COVID-19 and a Roadmap for Future Pandemics
Redaktion: Schachter, Steven C.; Bolton, Wade E.
29,95 €
29,95 €
inkl. MwSt.
Sofort per Download lieferbar
29,95 €
Als Download kaufen
29,95 €
inkl. MwSt.
Sofort per Download lieferbar
Accelerating Diagnostics in a Time of Crisis (eBook, ePUB)
The Response to COVID-19 and a Roadmap for Future Pandemics
Redaktion: Schachter, Steven C.; Bolton, Wade E.
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
- Geräte: eReader
- mit Kopierschutz
- eBook Hilfe
- Größe: 24.91MB
Andere Kunden interessierten sich auch für
- Froland Stig S. FrolandDuel Without End (eBook, ePUB)32,95 €
- Richard B. TenserNeurovirology (eBook, ePUB)39,95 €
- Michael V. McConnellFight Heart Disease Like Cancer (eBook, ePUB)22,95 €
- Steven Q. WangBeating Melanoma (eBook, ePUB)17,95 €
- John BrookeUnderstanding Epidemics (eBook, ePUB)3,99 €
- Stephen M. StahlPrescriber's Guide (eBook, ePUB)88,95 €
- Digital Health Care outside of Traditional Clinical Settings (eBook, ePUB)25,95 €
-
-
-
Produktdetails
- Verlag: Cambridge University Press
- Erscheinungstermin: 7. März 2024
- Englisch
- ISBN-13: 9781009397018
- Artikelnr.: 70913906
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Introduction Tania Fernandez; 1. Early detection
response
and surveillance of the covid-19 pandemic crisis Enrique Rabellino
Alexandra Smith and Marta Cohen; 2. Immune system responses to SARS-CoV-2 Adolfo Firpo-Betancourt; 3. Clinical management: a roadmap for one nyc hospital's response to the covid-19 pandemic Barbara Barnett
Yvette Calderon
Erick Eiting
Young Lee
Lina Miyakawa
Waleed Javaid and Saralynne Brown; 4. Contribution of radx to the rapid development and commercialization of covid-19 diagnostic assays Steven Schachter
John Collins
Michael Dempsey
Laura Gibson
Matthew Robinson and Paul Tessier; 5. Coordination of resources for the deployment of covid-19 diagnostic assays Brian Walsh
Maren Downing
Mia Cirrincoine
Adam Samuta
Kevin Leite
Sam Dolphin
Emily Muth and Jose Valdesuso; 6. Quality and risk management processes for diagnostic assays during an emergency pandemic response¿ Devon Campbell and Christie Johnson; 7. Development of assays to diagnose covid-19 Yuka Manabe and William Clarke; 8. Laboratory verification and clinical validation of covid-19 diagnostic assays Wilbur Lam
Leda Bassit
Anuradha Rao
Jennifer Frediani and Julie Sullivan; 9. Importance of timely sequencing
tracking and surveillance of emergent variants Anne Piantadosi
Jessica Lin
Morgan Greenleaf
Leda Bassit
Cassandra Wesselman and Yang Lu; 10. The RADx regulatory core and its role in covid-19 emergency use authorizations Erika Tyburski and Cathy Cambria; 11. Commercialization and market assessment of covid-19 assays Manuel Kingsley
Sunshine Moore and Heath Naquin; 12. Testing strategies to mitigate covid-19 disease spread Paul Tessier and Peko Hosoi; 13. A pandemic not just of infection but of inequality: the social impact of covid-19 Mara Aspinall and Liz Ruark; 14. Summary and path forward for future pandemics Wade Bolton and Steven Schachter.
response
and surveillance of the covid-19 pandemic crisis Enrique Rabellino
Alexandra Smith and Marta Cohen; 2. Immune system responses to SARS-CoV-2 Adolfo Firpo-Betancourt; 3. Clinical management: a roadmap for one nyc hospital's response to the covid-19 pandemic Barbara Barnett
Yvette Calderon
Erick Eiting
Young Lee
Lina Miyakawa
Waleed Javaid and Saralynne Brown; 4. Contribution of radx to the rapid development and commercialization of covid-19 diagnostic assays Steven Schachter
John Collins
Michael Dempsey
Laura Gibson
Matthew Robinson and Paul Tessier; 5. Coordination of resources for the deployment of covid-19 diagnostic assays Brian Walsh
Maren Downing
Mia Cirrincoine
Adam Samuta
Kevin Leite
Sam Dolphin
Emily Muth and Jose Valdesuso; 6. Quality and risk management processes for diagnostic assays during an emergency pandemic response¿ Devon Campbell and Christie Johnson; 7. Development of assays to diagnose covid-19 Yuka Manabe and William Clarke; 8. Laboratory verification and clinical validation of covid-19 diagnostic assays Wilbur Lam
Leda Bassit
Anuradha Rao
Jennifer Frediani and Julie Sullivan; 9. Importance of timely sequencing
tracking and surveillance of emergent variants Anne Piantadosi
Jessica Lin
Morgan Greenleaf
Leda Bassit
Cassandra Wesselman and Yang Lu; 10. The RADx regulatory core and its role in covid-19 emergency use authorizations Erika Tyburski and Cathy Cambria; 11. Commercialization and market assessment of covid-19 assays Manuel Kingsley
Sunshine Moore and Heath Naquin; 12. Testing strategies to mitigate covid-19 disease spread Paul Tessier and Peko Hosoi; 13. A pandemic not just of infection but of inequality: the social impact of covid-19 Mara Aspinall and Liz Ruark; 14. Summary and path forward for future pandemics Wade Bolton and Steven Schachter.
Introduction Tania Fernandez; 1. Early detection
response
and surveillance of the covid-19 pandemic crisis Enrique Rabellino
Alexandra Smith and Marta Cohen; 2. Immune system responses to SARS-CoV-2 Adolfo Firpo-Betancourt; 3. Clinical management: a roadmap for one nyc hospital's response to the covid-19 pandemic Barbara Barnett
Yvette Calderon
Erick Eiting
Young Lee
Lina Miyakawa
Waleed Javaid and Saralynne Brown; 4. Contribution of radx to the rapid development and commercialization of covid-19 diagnostic assays Steven Schachter
John Collins
Michael Dempsey
Laura Gibson
Matthew Robinson and Paul Tessier; 5. Coordination of resources for the deployment of covid-19 diagnostic assays Brian Walsh
Maren Downing
Mia Cirrincoine
Adam Samuta
Kevin Leite
Sam Dolphin
Emily Muth and Jose Valdesuso; 6. Quality and risk management processes for diagnostic assays during an emergency pandemic response¿ Devon Campbell and Christie Johnson; 7. Development of assays to diagnose covid-19 Yuka Manabe and William Clarke; 8. Laboratory verification and clinical validation of covid-19 diagnostic assays Wilbur Lam
Leda Bassit
Anuradha Rao
Jennifer Frediani and Julie Sullivan; 9. Importance of timely sequencing
tracking and surveillance of emergent variants Anne Piantadosi
Jessica Lin
Morgan Greenleaf
Leda Bassit
Cassandra Wesselman and Yang Lu; 10. The RADx regulatory core and its role in covid-19 emergency use authorizations Erika Tyburski and Cathy Cambria; 11. Commercialization and market assessment of covid-19 assays Manuel Kingsley
Sunshine Moore and Heath Naquin; 12. Testing strategies to mitigate covid-19 disease spread Paul Tessier and Peko Hosoi; 13. A pandemic not just of infection but of inequality: the social impact of covid-19 Mara Aspinall and Liz Ruark; 14. Summary and path forward for future pandemics Wade Bolton and Steven Schachter.
response
and surveillance of the covid-19 pandemic crisis Enrique Rabellino
Alexandra Smith and Marta Cohen; 2. Immune system responses to SARS-CoV-2 Adolfo Firpo-Betancourt; 3. Clinical management: a roadmap for one nyc hospital's response to the covid-19 pandemic Barbara Barnett
Yvette Calderon
Erick Eiting
Young Lee
Lina Miyakawa
Waleed Javaid and Saralynne Brown; 4. Contribution of radx to the rapid development and commercialization of covid-19 diagnostic assays Steven Schachter
John Collins
Michael Dempsey
Laura Gibson
Matthew Robinson and Paul Tessier; 5. Coordination of resources for the deployment of covid-19 diagnostic assays Brian Walsh
Maren Downing
Mia Cirrincoine
Adam Samuta
Kevin Leite
Sam Dolphin
Emily Muth and Jose Valdesuso; 6. Quality and risk management processes for diagnostic assays during an emergency pandemic response¿ Devon Campbell and Christie Johnson; 7. Development of assays to diagnose covid-19 Yuka Manabe and William Clarke; 8. Laboratory verification and clinical validation of covid-19 diagnostic assays Wilbur Lam
Leda Bassit
Anuradha Rao
Jennifer Frediani and Julie Sullivan; 9. Importance of timely sequencing
tracking and surveillance of emergent variants Anne Piantadosi
Jessica Lin
Morgan Greenleaf
Leda Bassit
Cassandra Wesselman and Yang Lu; 10. The RADx regulatory core and its role in covid-19 emergency use authorizations Erika Tyburski and Cathy Cambria; 11. Commercialization and market assessment of covid-19 assays Manuel Kingsley
Sunshine Moore and Heath Naquin; 12. Testing strategies to mitigate covid-19 disease spread Paul Tessier and Peko Hosoi; 13. A pandemic not just of infection but of inequality: the social impact of covid-19 Mara Aspinall and Liz Ruark; 14. Summary and path forward for future pandemics Wade Bolton and Steven Schachter.